Physician profile
Bradley A Fink
NPI 1265420939
$2,534.90
in general payments reported to CMS, 2019-2025
27 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $289 · 2021: $491 · 2022: $271 · 2023: $391 · 2024: $497 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,078.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,001.86 | 2020-2025 | Gamma, Accolade, Na |
| Abbott Laboratories | $360.32 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $254.79 | 2019-2025 | Gel-One Cross-Linked Hyaluronate |
| Endo Pharmaceuticals INC. | $93.44 | 2021-2023 | Xiaflex |
| Boston Scientific Corporation | $85.44 | 2022-2024 | Watchman Access System, Bodyguardian |
| Smith+Nephew, INC. | $65.18 | 2023-2024 | Accu-Pass, Healicoil, Biosure |
| Janssen Pharmaceuticals, INC | $57.96 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $57.28 | 2022-2023 | Lifevest |
| Merck Sharp & Dohme LLC | $53.67 | 2022-2025 | Verquvo |
| Heraeus Medical, LLC. | $48.95 | 2023 | Palacos |
| Novus Surgical Solutions LLC | $48.82 | 2021 | |
| Biedermann Motech, INC. | $44.34 | 2019-2022 | |
| Integra Lifesciences Corporation | $38.57 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acumed LLC | $37.51 | 2019 | |
| Zimvie INC. | $36.26 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $33.80 | 2023-2024 | Repatha |
| Kestra Medical Technology Services, INC. | $29.79 | 2025 | Assure Wcd |
| Medtronic USA, INC. | $29.03 | 2019 | |
| Ethicon US, LLC | $22.11 | 2019 | |
| Edwards Lifesciences Corporation | $21.71 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Wright Medical Technology, INC. | $20.81 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $18.94 | 2025 | |
| Pfizer INC. | $17.49 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $17.28 | 2024 | Lokelma |
| Liberty Surgical INC. | $16.84 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.38 | 2021 | |
| Orthofix Medical, INC. | $8.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Fink listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.